Search results for "OUTCOME"

showing 10 items of 5148 documents

Mortality and cause of death in mucopolysaccharidosis type II-a historical review based on data from the Hunter Outcome Survey (HOS).

2009

Mucopolysaccharidosis type II (MPS II or Hunter syndrome) is a progressive, multisystemic disease caused by a deficiency of iduronate-2-sulfatase. Patients with the severe form of the disease have cognitive impairment and typically die in the second decade of life. Patients with the less severe form do not experience significant cognitive involvement and may survive until the fifth or sixth decade of life. We studied the relationship of both severity of MPS II and the time period in which patients died with age at death in 129 patients for whom data were entered retrospectively into HOS (Hunter Outcome Survey), the only large-scale, multinational observational study of patients with MPS II.…

AdultMalemedicine.medical_specialtyPediatricsAdolescentIdursulfaseIduronate SulfataseCohort StudiesYoung AdultCause of DeathEpidemiologyGeneticsmedicineHumansMucopolysaccharidosis type IIYoung adultChildGenetics (clinical)Cause of deathMucopolysaccharidosis IIRetrospective StudiesMPS type IIbusiness.industryData CollectionAge FactorsInfantHunter syndromeEnzyme replacement therapymedicine.diseaseSurgeryTreatment OutcomeChild PreschoolFemaleSettore MED/35 - MALATTIE CUTANEE E VENEREEbusinessmedicine.drugCohort studyJournal of inherited metabolic disease
researchProduct

Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control.

2013

Background Chronic urticaria is a frequent and debilitating skin disease. Its symptoms commonly fluctuate considerably from day to day. As of yet, the only reliable tool to assess disease activity is the Urticaria Activity Score, which prospectively documents the signs and symptoms of urticaria for several days. Objective We sought to develop and validate a novel patient-reported outcome instrument to retrospectively assess urticaria control, the Urticaria Control Test (UCT). Methods Potential UCT items were developed by using established methods (literature research and expert and patient involvement). Subsequently, item reduction was performed by using a combined approach, applying impact…

AdultMalemedicine.medical_specialtyPediatricsAdolescentUrticariaVisual analogue scaleIntraclass correlationImmunologyMEDLINEDiseaseimmune system diseasesGermanyparasitic diseasesImmunology and AllergyMedicineHumansskin and connective tissue diseasesAgedRetrospective StudiesAged 80 and overReceiver operating characteristicbusiness.industryRetrospective cohort studyMiddle AgedControl testPhysical therapyPatient-reported outcomeFemalebusinessThe Journal of allergy and clinical immunology
researchProduct

Assessing age and gender in studies of breakthrough pain medications

2014

AbstractObjective:The present review was performed to identify possible differences observed between adults and elderly patients and between males and females in randomized clinical trials of breakthrough pain (BTP).Methods:A systematic search of the existing literature from 1998 to September 2013 was performed. Randomized clinical trials reporting data on older patients were selected.Results:Sixteen comparative studies were selected. The age range of inclusion criteria patients was mainly between 18–80 or ≥18 years. In some cases this data was unreported. The mean age of patients was 48–64 years, but information regarding the number of elderly patients was present in three studies only. Ge…

AdultMalemedicine.medical_specialtyPediatricsBreakthrough PainSubgroup analysislaw.inventionAge and genderSex FactorsRandomized controlled trialOlder patientslawNeoplasmsmedicineHumansPsychiatryAdverse effectAgedRandomized Controlled Trials as Topicbusiness.industryBreakthrough PainAge FactorsGender distributionGeneral Medicinebreakthrough pain cancer painAnalgesics OpioidTreatment OutcomeFemaleCancer painbusinessCurrent Medical Research and Opinion
researchProduct

Prognosis of Patients Listed for a Heart Transplant During the Pretransplant Period: Does Diabetes Matter?

2013

Whether patients with advanced heart failure and diabetes mellitus (DM) should be listed for heart transplantation (HTx) remains controversial due to conflicting findings regarding their post-HTx survival (1–3). We studied HTx candidates with and without DM during the pre-HTx period, examining multiple waiting list outcomes. Patients were enrolled in the Waiting for a New Heart Study, a multisite observational study of 318 adult (≥18 years of age) patients (aged 53 ± 11 years; 18% female) who were newly listed for HTx with Eurotransplant between April 2005 and December 2006 (4). Informed consent and ethics approval were obtained (4). Characteristics at the time of listing included age, DM, …

AdultMalemedicine.medical_specialtyPediatricsEndocrinology Diabetes and Metabolismmedicine.medical_treatmentTreatment outcomeInformed consentDiabetes mellitusDiabetes MellitusInternal MedicinemedicineHumansOnline Letters: ObservationsHeart FailureAdvanced and Specialized NursingHeart transplantationbusiness.industryMiddle AgedPrognosismedicine.diseaseSurgeryTreatment OutcomeWaiting listHeart failureHeart TransplantationFemaleObservational studybusinessDiabetes Care
researchProduct

One-year follow-up of cardiac anxiety syndromes. Outcome and predictors of course.

1987

In a representative sample (n = 31) of patients with panic attacks and a cardiac anxiety syndrome, a prospective follow-up study after a 1-year interval was performed. At the follow-up assessment 33% of the patients were in remission, whereas the majority of patients had an unfavorable course. Avoidance behavior and female sexual status were found to be predictive for an unfavorable course. Within a matched-pair design controlled for age and sex, no difference between panic disorder with and without cardiac anxiety syndrome was observed in any psychosocial or psychopathological outcome variable. This result is an argument against the validity of the subtype cardiac anxiety syndrome.

AdultMalemedicine.medical_specialtyPediatricsSex FactorsmedicineAvoidance LearningHumansPharmacology (medical)PsychiatryBiological PsychiatryDepression (differential diagnoses)General NeurosciencePanic disorderPanicHeartGeneral MedicineFearSemiologymedicine.diseasePrognosisAnxiety DisordersPanicOutcome (probability)Psychiatry and Mental healthNeuropsychology and Physiological PsychologyAnxietyFemalemedicine.symptomPsychologyPsychosocialPsychopathologyFollow-Up StudiesEuropean archives of psychiatry and neurological sciences
researchProduct

Long-term outcomes of short-term and long-term psychosomatic inpatient treatment and their predictors

2007

Abstract Objectives The Clinic for Psychosomatic Medicine and Psychotherapy at the University Giessen, Germany, offers short-term (STT) and long-term inpatient therapy (LTT). Methods In a prospective, 3-year follow-up study, we examined therapeutic indication, short- and long-term results, outcome predictors, and the utilization of aftercare for both settings. Results STT patients were more frequently acutely ill, suffered from stronger symptomatic manifestations, and were more frequently employed. LTT patients had a greater rate of chronic psychosomatic disorders, personality disorders and somatic comorbidity. In both settings, distress strongly declined during inpatient therapy and remain…

AdultMalemedicine.medical_specialtyPediatricsTime FactorsAftercareSeverity of Illness IndexInternational Classification of DiseasesPredictive Value of TestsmedicineHumansProspective StudiesPsychiatryDemographybusiness.industryPsychosomaticsPublic healthPsychosomatic medicineSocial environmentmedicine.diseasePsychophysiologic DisordersPersonality disordersMental healthComorbidityHospitalizationPsychiatry and Mental healthClinical PsychologyDistressTreatment OutcomebusinessFollow-Up StudiesJournal of Psychosomatic Research
researchProduct

Prevention of haemophilic arthropathy during childhood. May common orthopaedic management be extrapolated from patients without inhibitors to patient…

2008

We recommend prophylaxis in haemophilic children with an inhibitor as a way of preventing the musculoskeletal impairment that is likely to affect them. This approach has been used for children without inhibitors with excellent results. If prophylaxis is not feasible, we suggest that intensive on-demand treatment should be given. Two agents, recombinant activated FVII (rFVIIa) and activated prothrombin complex concentrates (aPCC), are currently used to control haemostasis either for prophylaxis or intensive on-demand treatment. As it is recombinant, rFVIIa would seem more appropriate to be employed in children. aPCC could be used in adults, or in the event of an unsatisfactory response to rF…

AdultMalemedicine.medical_specialtyPediatricsTime FactorsEvidence-based practiceAdolescentFactor VIIaHemophilia AHaemophiliaFactor IXYoung AdultHemarthrosismedicineOrthopaedic proceduresHumansPain ManagementOrthopedic ProceduresChildIntensive care medicinePhysical Therapy ModalitiesGenetics (clinical)Randomized Controlled Trials as TopicRetrospective StudiesHaemophilic arthropathySynovitisBlood Coagulation Factor InhibitorsCoagulantsbusiness.industryMusculoskeletal impairmentHematologyGeneral MedicinePerioperativemedicine.diseaseSkeletal maturityBlood Coagulation FactorsRecombinant ProteinsCartilageTreatment OutcomeChild PreschoolPractice Guidelines as TopicbusinessPROTHROMBIN COMPLEXHaemophilia : the official journal of the World Federation of Hemophilia
researchProduct

Presentation and outcome of tuberculous meningitis in adults in the province of Castellon, Spain: a retrospective study

2008

SUMMARYThe aim of this study was to describe the epidemiological and clinical features of tuberculous meningitis in the province of Castellon, Spain. Retrospective analysis was done of all cases attended during the last 15 years. The following groups of variables were assessed: sociodemographic data, medical antecedents, clinical presentation, imaging study results, analyses, cerebrospinal fluid microbiology, treatment, and outcome. Twenty-nine cases were included. Median of age of patients was 34 years, and 17 (59%) were males. HIV infection was present in 15 cases (52%), fever, the most common symptom, occurred in 27 (93%), nuchal rigidity was noted in only 16 (55%), and syndrome of inapp…

AdultMalemedicine.medical_specialtyPediatricsTuberculosisAdolescentFeverEpidemiologyAntitubercular AgentsHIV InfectionsDiseaseTuberculous meningitisInappropriate ADH SyndromeCentral nervous system diseaseCerebrospinal fluidEpidemiologymedicineHumansLungAgedRetrospective Studiesmedicine.diagnostic_testbusiness.industryAnemiaRetrospective cohort studyMiddle Agedmedicine.diseaseOriginal PapersMuscle RigiditySurgeryCholesterolTreatment OutcomeInfectious DiseasesSpainTuberculosis MeningealFemaleRadiography ThoracicChest radiographbusinessHypoalbuminemiaEpidemiology and Infection
researchProduct

Helicobacter pylori infection does not affect the early rebleeding rate in patients with peptic ulcer bleeding after successful endoscopic hemostasis…

2003

Background and study aims Eradication of Helicobacter pylori infection can reduce the rebleeding rate of peptic ulcer bleeding in the long term. There are few data on the influence of H. pylori on the rebleeding rate in the acute phase of bleeding however. We therefore prospectively investigated the influence of H. pylori infection on the early rebleeding rate in patients who had undergone successful endoscopic hemostasis treatment for peptic ulcer bleeding. Patients and methods Between January 1996 and November 2000 all patients with peptic ulcer bleeding were evaluated consecutively. The diagnosis of H. pylori infection was made at index endoscopy, using histology and the rapid urease tes…

AdultMalemedicine.medical_specialtyPeptic UlcerAdolescentRapid urease testPeptic Ulcer HemorrhageGastroenterologyStatistics NonparametricHelicobacter InfectionsRecurrenceInternal medicineGastroscopymedicineHumansProspective StudiesProspective cohort studyAgedProbabilityAged 80 and overbiologyHelicobacter pyloribusiness.industryHemostasis EndoscopicGastroenterologyHelicobacter pyloriMiddle Agedbiology.organism_classificationSurgeryLogistic ModelsPeptic Ulcer HemorrhageTreatment OutcomeForrest classificationHemostasisFemaleGastritismedicine.symptomComplicationbusinessFollow-Up StudiesEndoscopy
researchProduct

Laparoscopy is an available alternative to open surgery in the treatment of perforated peptic ulcers: A retrospective multicenter study

2018

Abstract Background Perforated peptic ulcers (PPU) remain one of the most frequent causes of death. Their incidence are largely unchanged accounting for 2–4% of peptic ulcers and remain the second most frequent abdominal cause of perforation and of indication for gastric emergency surgery. The minimally invasive approach has been proposed to treat PPU however some concerns on the offered advantages remain. Methods Data on 184 consecutive patients undergoing surgery for PPU were collected. Likewise, perioperative data including shock at admission and interval between admission and surgery to evaluate the Boey’s score. It was recorded the laparoscopic or open treatments, the type of surgical …

AdultMalemedicine.medical_specialtyPepticPerforation (oil well)Operative Timelcsh:Surgery030230 surgerylaw.invention03 medical and health sciences0302 clinical medicinePeptic Ulcer PerforationPostoperative ComplicationsRandomized controlled triallawIntensive caremedicineHumansLaparoscopyRetrospective StudiesAgedAged 80 and overFramingham Risk Scoremedicine.diagnostic_testbusiness.industryPeptic ulcer perforationStomachlcsh:RD1-811General MedicinePerioperativeLength of StayMiddle AgedSurgeryTreatment Outcome030220 oncology & carcinogenesisFemaleLaparoscopySurgerybusiness
researchProduct